These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

801 related articles for article (PubMed ID: 19405003)

  • 101. Use of the Sharp and Larsen scoring methods in the assessment of radiographic progression in juvenile idiopathic arthritis.
    Rossi F; Di Dia F; Galipò O; Pistorio A; Valle M; Magni-Manzoni S; Ruperto N; Tomà P; Martini A; Ravelli A
    Arthritis Rheum; 2006 Oct; 55(5):717-23. PubMed ID: 17013855
    [TBL] [Abstract][Full Text] [Related]  

  • 102. Extension study of participants from the trial of early aggressive therapy in juvenile idiopathic arthritis.
    Wallace CA; Ringold S; Bohnsack J; Spalding SJ; Brunner HI; Milojevic D; Schanberg LE; Higgins GC; O'Neil KM; Gottlieb BS; Hsu J; Punaro MG; Kimura Y; Hendrickson A
    J Rheumatol; 2014 Dec; 41(12):2459-65. PubMed ID: 25179849
    [TBL] [Abstract][Full Text] [Related]  

  • 103. Treat-to-target study for improved outcome in polyarticular juvenile idiopathic arthritis.
    Klein A; Minden K; Hospach A; Foeldvari I; Weller-Heinemann F; Trauzeddel R; Huppertz HI; Horneff G
    Ann Rheum Dis; 2020 Jul; 79(7):969-974. PubMed ID: 32299797
    [TBL] [Abstract][Full Text] [Related]  

  • 104. Disease activity and damage in juvenile idiopathic arthritis: methotrexate era versus biologic era.
    Giancane G; Muratore V; Marzetti V; Quilis N; Benavente BS; Bagnasco F; Alongi A; Civino A; Quartulli L; Consolaro A; Ravelli A
    Arthritis Res Ther; 2019 Jul; 21(1):168. PubMed ID: 31287015
    [TBL] [Abstract][Full Text] [Related]  

  • 105. The correlation between the Childhood Health Assessment Questionnaire and disease activity in juvenile idiopathic arthritis.
    Sontichai W; Vilaiyuk S
    Musculoskeletal Care; 2018 Sep; 16(3):339-344. PubMed ID: 29573557
    [TBL] [Abstract][Full Text] [Related]  

  • 106. Sleep and its relationship to pain, dysfunction, and disease activity in juvenile idiopathic arthritis.
    Shyen S; Amine B; Rostom S; E L Badri D; Ezzahri M; Mawani N; Moussa F; Gueddari S; Wabi M; Abouqal R; Chkirate B; Hajjaj-Hassouni N
    Clin Rheumatol; 2014; 33(10):1425-31. PubMed ID: 24135889
    [TBL] [Abstract][Full Text] [Related]  

  • 107. Relation of interleukin-6, TNF-alpha and interleukin-1alpha with disease activity and severity in juvenile idiopathic arthritis patients.
    Spîrchez M; Samaşca G; Iancu M; Bolba C; Miu N
    Clin Lab; 2012; 58(3-4):253-60. PubMed ID: 22582498
    [TBL] [Abstract][Full Text] [Related]  

  • 108. Toward a treat-to-target approach in the management of juvenile idiopathic arthritis.
    Consolaro A; Negro G; Lanni S; Solari N; Martini A; Ravelli A
    Clin Exp Rheumatol; 2012; 30(4 Suppl 73):S157-62. PubMed ID: 23072725
    [TBL] [Abstract][Full Text] [Related]  

  • 109. Association of hand grip strength with disease activity, disability and quality of life in children and adolescents with Juvenile Idiopathic Arthritis.
    Rashed AM; Abdel-Wahab N; Moussa EMM; Hammam N
    Adv Rheumatol; 2018 Jun; 58(1):11. PubMed ID: 30657067
    [TBL] [Abstract][Full Text] [Related]  

  • 110. Canakinumab in patients with systemic juvenile idiopathic arthritis and active systemic features: results from the 5-year long-term extension of the phase III pivotal trials.
    Ruperto N; Brunner HI; Quartier P; Constantin T; Wulffraat NM; Horneff G; Kasapcopur O; Schneider R; Anton J; Barash J; Berner R; Corona F; Cuttica R; Fouillet-Desjonqueres M; Fischbach M; Foster HE; Foell D; Radominski SC; Ramanan AV; Trauzeddel R; Unsal E; Levy J; Vritzali E; Martini A; Lovell DJ;
    Ann Rheum Dis; 2018 Dec; 77(12):1710-1719. PubMed ID: 30269054
    [TBL] [Abstract][Full Text] [Related]  

  • 111. Temporomandibular joint involvement in Juvenile Idiopathic Arthritis: reliability and validity of a screening protocol for the rheumatologist.
    Steenks MH; Giancane G; de Leeuw RR; Bronkhorst EM; van Es RJ; Koole R; van Bruggen HW; Wulffraat NM
    Pediatr Rheumatol Online J; 2015 May; 13():15. PubMed ID: 25947157
    [TBL] [Abstract][Full Text] [Related]  

  • 112. Effect of methotrexate on the temporomandibular joint and facial morphology in juvenile rheumatoid arthritis patients.
    Ince DO; Ince A; Moore TL
    Am J Orthod Dentofacial Orthop; 2000 Jul; 118(1):75-83. PubMed ID: 10893476
    [TBL] [Abstract][Full Text] [Related]  

  • 113. PROMIS Computer Adaptive Tests and Their Correlation With Disease Activity in Juvenile Idiopathic Arthritis.
    Trachtman R; Wang CM; Murray E; Szymonifka J; Pan N; Adams AB; Taber SF; Onel KB; Mandl LA
    J Clin Rheumatol; 2021 Jun; 27(4):131-135. PubMed ID: 31743268
    [TBL] [Abstract][Full Text] [Related]  

  • 114. Adapted versions of the Sharp/van der Heijde score are reliable and valid for assessment of radiographic progression in juvenile idiopathic arthritis.
    Ravelli A; Ioseliani M; Norambuena X; Sato J; Pistorio A; Rossi F; Ruperto N; Magni-Manzoni S; Ullmann N; Martini A
    Arthritis Rheum; 2007 Sep; 56(9):3087-95. PubMed ID: 17763418
    [TBL] [Abstract][Full Text] [Related]  

  • 115. Omega-3 fatty acids in juvenile idiopathic arthritis: effect on cytokines (IL-1 and TNF-α), disease activity and response criteria.
    Gheita T; Kamel S; Helmy N; El-Laithy N; Monir A
    Clin Rheumatol; 2012 Feb; 31(2):363-6. PubMed ID: 21922187
    [TBL] [Abstract][Full Text] [Related]  

  • 116. Tumor necrosis factor-α -308 A/G gene polymorphism in children with juvenile idiopathic arthritis: relation to disease activity, damage, and functional status.
    El Gazzar II; Fathy HM; Gheita TA; Nour El-Din AM; Rasheed EA; Bassyouni RH; Kenawy SA
    Clin Rheumatol; 2017 Aug; 36(8):1757-1763. PubMed ID: 28593608
    [TBL] [Abstract][Full Text] [Related]  

  • 117. Towards stratified treatment of JIA: machine learning identifies subtypes in response to methotrexate from four UK cohorts.
    Shoop-Worrall SJW; Lawson-Tovey S; Wedderburn LR; Hyrich KL; Geifman N;
    EBioMedicine; 2024 Feb; 100():104946. PubMed ID: 38194741
    [TBL] [Abstract][Full Text] [Related]  

  • 118. Aggressive combination drug therapy in very early polyarticular juvenile idiopathic arthritis (ACUTE-JIA): a multicentre randomised open-label clinical trial.
    Tynjälä P; Vähäsalo P; Tarkiainen M; Kröger L; Aalto K; Malin M; Putto-Laurila A; Honkanen V; Lahdenne P
    Ann Rheum Dis; 2011 Sep; 70(9):1605-12. PubMed ID: 21623000
    [TBL] [Abstract][Full Text] [Related]  

  • 119. Efficacy and safety of repeat courses of rituximab treatment in patients with severe refractory juvenile idiopathic arthritis.
    Alexeeva EI; Valieva SI; Bzarova TM; Semikina EL; Isaeva KB; Lisitsyn AO; Denisova RV; Chistyakova EG
    Clin Rheumatol; 2011 Sep; 30(9):1163-72. PubMed ID: 21384257
    [TBL] [Abstract][Full Text] [Related]  

  • 120. The magnitude of early response to methotrexate therapy predicts long-term outcome of patients with juvenile idiopathic arthritis.
    Bartoli M; Tarò M; Magni-Manzoni S; Pistorio A; Traverso F; Viola S; Magnani A; Gasparini C; Martini A; Ravelli A
    Ann Rheum Dis; 2008 Mar; 67(3):370-4. PubMed ID: 17660217
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 41.